Secondary Findings
Showing 9951 - 9975 of >10,000
COPD, CHF Trial in Lumezzane (Spirotiger)
Completed
- Chronic Obstructive Pulmonary Disease
- Congestive Heart Failure
- Spirotiger
-
Lumezzane, Brescia, ItalyFondazione Salvatore Maugeri
Mar 16, 2022
Microsampling Assays for Immunosuppressive Drugs in Children
Withdrawn
- Immunosuppression
- Microsampling
-
Philadelphia, PennsylvaniaChildren's Hospital of Phildelphia
Mar 17, 2022
HIV-1-infection Trial in Baltimore (Mobile-enhanced Engagement Intervention)
Active, not recruiting
- HIV-1-infection
- Mobile-enhanced Engagement Intervention
-
Baltimore, MarylandCenter for Adolescent and Young Adult Health at Johns Hopkins Ha
Mar 29, 2022
Covid19 Trial in Clermont-Ferrand (nasopharyngeal swabbing procedure (self swabbing first), nasopharyngeal swabbing procedure
Not yet recruiting
- Covid19
- nasopharyngeal swabbing procedure (self swabbing first)
- nasopharyngeal swabbing procedure (conventionnal swabbing first)
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Apr 2, 2021
Foramen Ovale, Patent, Nickel Sensitivity, Dermatitis Contact Irritant Trial in Athens (Percutaneous Patent Foramen Ovale
Recruiting
- Foramen Ovale, Patent
- +3 more
- Percutaneous Patent Foramen Ovale Closure
-
Athens, Attica, GreeceFirst Department of Cardiology, National and Kapodistrian Univer
May 11, 2021
Religious or Spiritual Problem Trial in New York (Psilocybin)
Completed
- Religious or Spiritual Problem
-
New York, New YorkNYU Langone Medical Center/Tisch Hospital
Feb 10, 2022
Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)
Enrolling by invitation
- Autism Spectrum Disorder
- +6 more
- SRS 2, CBCL, BRIEF-P
-
Penrith, New South Wales, Australia
- +57 more
Sep 18, 2022
Dyspnea Trial in Paris, Argenteuil (Specific exercise rehabilitation treatment, No specific exercise rehabilitation treatment)
Active, not recruiting
- Dyspnea
- Specific exercise rehabilitation treatment
- No specific exercise rehabilitation treatment
-
Paris, Ile-de-France, France
- +2 more
Aug 3, 2022
Diabetes, Type 2, Hypertension, Dyslipidemias Trial in Shijiazhuang (SMARTHealth Diabetes)
Completed
- Diabetes Mellitus, Type 2
- +2 more
- SMARTHealth Diabetes
-
Shijiazhuang, Hebei, China
- +1 more
Mar 11, 2021
Physical Activity, Healthy Promotion Trial in Victoria (Digital Health Online Platform)
Completed
- Physical Activity, Healthy Promotion
- Digital Health Online Platform
-
Victoria, British Columbia, Canada
- +1 more
Oct 19, 2021
Breast Cancer Trial in Goyang-si, Seoul (Omission of intraoperative frozen section biopsy for margin status, Frozen section
Recruiting
- Breast Cancer
- Omission of intraoperative frozen section biopsy for margin status
- Frozen section biopsy for margin status
-
Goyang-si, Korea, Republic of
- +1 more
Oct 13, 2021
Complication Trial in Dongguan, Guangzhou (autologous cord blood mononuclear cells, normal saline)
Recruiting
- Complication
- autologous cord blood mononuclear cells
- normal saline
-
Dongguan, Guangdong, China
- +1 more
Oct 9, 2021
Dementia Trial in Augusta (Otago Exercise Program)
Recruiting
- Dementia
- Otago Exercise Program
-
Augusta, GeorgiaAugusta University
Aug 3, 2022
Burns Trial in Aurora (Fresh Frozen Plasma)
Recruiting
- Burns
- Fresh Frozen Plasma
-
Aurora, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Feb 22, 2022
Glioma, Glioma of Brain, Brain Tumor Trial in Durham (Lacosamide, Levetiracetam)
Terminated
- Glioma
- +2 more
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Dec 2, 2021
Diabetes, Type 2, Heart Failure Preserved Ejection Fraction Trial in Lumezzane (Evaluation of central and peripheral
Recruiting
- Diabetes Mellitus, Type 2
- Heart Failure Preserved Ejection Fraction
- Evaluation of central and peripheral neuromuscular fatigue
-
Lumezzane, Brescia, ItalyIstituti Clinici Scientifici Maugeri IRCCS
Sep 21, 2023
Long COVID Trial in Hong Kong (Chinese medicine nutritional supplement Cs4)
Recruiting
- Long COVID
- Chinese medicine nutritional supplement Cs4
-
Hong Kong, ChinaThe School of Chinese Medicine, HKU
Sep 26, 2023
Ischemic Stroke Trial in Izmir (Masimo O3 Regional Oximetry)
Recruiting
- Ischemic Stroke
- Masimo O3 Regional Oximetry
-
İzmir, Bornova, TurkeyEge University, Department of Emergency Medicine
Mar 22, 2022
Bladder Cancer Trial in Athens (Durvalumab)
Active, not recruiting
- Bladder Cancer
- Durvalumab
-
Athens, Attica, GreeceHellenic GenitoUrinary Cancer Group
Mar 22, 2022
Multidisciplinary Mobile Unit for Preventing Hospitalization of
Terminated
- Frailty
- +5 more
- Multidisciplinary Mobile Unit (MMU)
-
Parma, Emilia-Romagna, ItalyUO Medicina Interna e Lungodegenza Critica, Azienda Ospedaliero-
Jan 12, 2021
Thrombocytopenia, Mesenchymal Stem Cells Trial in Tianjin (Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs))
Recruiting
- Thrombocytopenia
- Mesenchymal Stem Cells
- Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
-
Tianjin, Tianjin, ChinaYunfei Chen
Jun 30, 2021
General Practitioners in France (Echo-MG)
Not yet recruiting
- Point of Care Ultrasound
-
Paris, FranceDepartement de Medecine Generale Sorbonne
May 10, 2021
Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Istanbul (Analgesia management; group ESPB and RIB)
Completed
- Breast Cancer
- +2 more
- Analgesia management; group ESPB and RIB
-
Istanbul, Bagcilar, TurkeyIstanbul Medipol University Hospital
Jan 20, 2022